Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
21Shares: Bitcoin year-end base target price is $100,000

21Shares: Bitcoin year-end base target price is $100,000

Odaily星球日报Odaily星球日报2026/06/24 11:46
Show original

Odaily reports that, according to the mid-year crypto market report published by 21Shares, Bitcoin is expected to reach a peak of around $126,000 in October 2025, with a baseline target price of $100,000 by the end of 2026.

The report indicates that, as of May 2026, the global crypto ETP assets under management are approximately $140 billion, with a total holding of 1.25 million Bitcoins. Additionally, it forecasts that market trading volume will reach $57.5 billion by the end of May; the total value locked in DeFi will remain around $140 billion; within Ethereum Layer 2 networks, Base, Arbitrum, and Optimism account for about 83% of total DeFi value locked; the size of tokenized assets on public blockchains is $31 billion, including $15 billion in tokenized US Treasuries. (The Block)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy

Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.

智通财经•2026/10/12 23:31

BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

智通财经•2026/10/12 23:27
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review

Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).

智通财经•2026/10/12 23:11